Related references
Note: Only part of the references are listed.A Reproducible and Scalable Process for Manufacturing a Pfs48/45 Based Plasmodium falciparum Transmission-Blocking Vaccine
Susheel K. Singh et al.
FRONTIERS IN IMMUNOLOGY (2021)
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial
Mehreen S. Datoo et al.
LANCET (2021)
Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites
Roos M. de Jong et al.
IMMUNOLOGICAL REVIEWS (2020)
The Plasmodium falciparum circumsporozoite protein produced in Lactococcus lactis is pure and stable
Susheel K. Singh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Malaria vaccines since 2000: progress, priorities, products
Patrick E. Duffy et al.
NPJ VACCINES (2020)
Identification of domains within Pfs230 that elicit transmission blocking antibody responses
Mayumi Tachibana et al.
VACCINE (2019)
Pfs230 and Pfs48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against Plasmodium falciparum
Susheel K. Singh et al.
FRONTIERS IN IMMUNOLOGY (2019)
The Pfs230 N-terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission-blocking vaccine candidate
Shwu-Maan Lee et al.
MALARIA JOURNAL (2019)
The Complement System Contributes to Functional Antibody Mediated Responses Induced by Immunization with Plasmodium falciparum Malaria Sporozoites
Marije C. Behet et al.
INFECTION AND IMMUNITY (2018)
Lactococcus lactis provides an efficient platform for production of disulfide-rich recombinant proteins from Plasmodium falciparum
Susheel K. Singh et al.
MICROBIAL CELL FACTORIES (2018)
A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein
Joshua Tan et al.
NATURE MEDICINE (2018)
A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite
Neville K. Kisalu et al.
NATURE MEDICINE (2018)
Improved Titers against Influenza Drift Variants with a Nanoparticle Vaccine
Vivek Shinde et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity
Will J. R. Stone et al.
NATURE COMMUNICATIONS (2018)
Synergy in anti malarial pre-erythrocytic and transmission-blocking antibodies is achieved by reducing parasite density
Ellie Sherrard-Smith et al.
ELIFE (2018)
Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal 'C-tag'
Jing Jin et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2017)
Naturally Acquired Antibodies Target the Glutamate-Rich Protein on Intact Merozoites and Predict Protection Against Febrile Malaria
Ikhlaq Hussain Kana et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Construct design, production, and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccine
Susheel K. Singh et al.
MICROBIAL CELL FACTORIES (2017)
Structural basis for antibody recognition of the NANP repeats in Plasmodium falciparum circumsporozoite protein
David Oyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Naturally acquired immunity to sexual stage P. falciparum parasites
Will J. R. Stone et al.
PARASITOLOGY (2016)
A Comprehensive Analysis of Plasmodium Circumsporozoite Protein Binding to Hepatocytes
Jinghua Zhao et al.
PLOS ONE (2016)
A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children
Sodiomon B. Sirima et al.
VACCINE (2016)
Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice
Karin Lovgren Bengtsson et al.
VACCINE (2016)
Transmission- blocking activity of antibodies to Plasmodium falciparum GLURP.10C chimeric protein formulated in different adjuvants
Will Roeffen et al.
MALARIA JOURNAL (2015)
A Plasmodium falciparum 48/45 single epitope R0.6C subunit protein elicits high levels of transmission blocking antibodies
Susheel K. Singh et al.
VACCINE (2015)
Classification of Intrinsically Disordered Regions and Proteins
Robin van der Lee et al.
CHEMICAL REVIEWS (2014)
A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages
Michael Theisen et al.
VACCINE (2014)
Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice
Sofia E. Magnusson et al.
VACCINE (2014)
Fusion protein linkers: Property, design and functionality
Xiaoying Chen et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Matrix-M (TM) adjuvant: enhancing immune responses by 'setting the stage' for the antigen
Karin Lovgren Bengtsson et al.
EXPERT REVIEW OF VACCINES (2013)
Key roles of adjuvants in modern vaccines
Steven G. Reed et al.
NATURE MEDICINE (2013)
Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice
Sofia E. Magnusson et al.
VACCINE (2013)
Measuring the blockade of malaria transmission - An analysis of the Standard Membrane Feeding Assay
Thomas S. Churcher et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2012)
Matrix-M™ Adjuvant Induces Local Recruitment, Activation and Maturation of Central Immune Cells in Absence of Antigen
Jenny M. Reimer et al.
PLOS ONE (2012)
N-Terminal Prodomain of Pfs230 Synthesized Using a Cell-Free System Is Sufficient To Induce Complement-Dependent Malaria Transmission-Blocking Activity
Mayumi Tachibana et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2-A GLURP-MSP3 fusion protein malaria vaccine candidate
Susana Lousada-Dietrich et al.
VACCINE (2011)
Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambarene, Gabon
Benjamin Mordmueller et al.
VACCINE (2010)
Structure of the Plasmodium falciparum Circumsporozoite Protein, a Leading Malaria Vaccine Candidate
Matthew L. Plassmeyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Generalized linear mixed models: a practical guide for ecology and evolution
Benjamin M. Bolker et al.
TRENDS IN ECOLOGY & EVOLUTION (2009)
Share Paper
